21
NPS Score
VS
Biogen Claimed Company
- EMPLOYEE
PARTICIPANTS - 193
- TOTAL
RATINGS
Karyopharm Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 90
- TOTAL
RATINGS
Biogen vs Karyopharm Therapeutics
Compare Biogen versus Karyopharm Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 193 employees and customers of Biogen and 90 employees and customers of Karyopharm Therapeutics.
Biogen
Biogen's brand is ranked #388 in the list of Global Top 1000 Brands, as rated by customers of Biogen. Their current market cap is $42.46B.
Karyopharm Therapeutics
Karyopharm Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Karyopharm Therapeutics. Their current market cap is $753.30M.
4/5
Product Quality
5/5
3.8/5
Pricing
5/5
3.8/5
Customer Service
5/5
| 53% | Promoters |
|---|---|
| 15% | Passive |
| 32% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 79
See how Biogen compares to its competitors
See how Karyopharm Therapeutics compares to its competitors
Working at Biogen vs Working at Karyopharm Therapeutics
66 / 100
CEO Rating
82 / 100
CEO Rating
Winner by 16%
Biogen
Biogen doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Karyopharm Therapeutics
Employees at Karyopharm Therapeutics rate their CEO, Richard Paulson, 82/100. This score is 16% higher than the scores of Biogen's CEO, Michel Vounatsos. Employees in the IT and Sales departments rate Richard Paulson the highest.